Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ANROAlto Neuroscience, Inc.

NYSE · CIK 0001999480
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts197

Identity from submissions API

NameAlto Neuroscience, Inc.
CIK0001999480
TickersANRO
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN834210124
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone773-255-5012
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW
CA
94041
CA
Mailing address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW
CA
94041
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

200 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 FORM 4 0001791413-26-000002 30076
2026-11-16 144 xsl144X01/primary_doc.xml 0001950047-26-011183 001-41944 261562168 33 5009
2026-11-10 10-Q 10-Q 0001999480-26-000031 001-41944 261540981 34 9193524 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001999480-26-000030 001-41944 261540493 34 227273 1 1
2026-10-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001537 005-94343 261505360 34 7364
2026-10-05 4 FORM 4 0002009130-26-000006 7285
2026-10-01 4 FORM 4 0002009130-26-000004 20113
2026-09-29 144 xsl144X01/primary_doc.xml 0001950047-26-009858 001-41944 261424139 33 5005
2026-08-27 8-K 8-K 5.02,9.01 0001999480-26-000024 001-41944 261331851 34 165930 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352632 005-94343 261283721 34 11858
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003498 005-94343 261281331 34 10746
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005199 005-94343 261276409 34 11136
2026-08-12 10-Q 10-Q 0001999480-26-000023 001-41944 261267941 34 8627024 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001999480-26-000022 001-41944 261267643 34 236323 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002170 005-94343 261206072 34 10774
2026-07-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000361 005-94343 261187442 34 15924
2026-07-14 8-K FORM 8-K 1.01,9.01 0001104659-26-083274 001-41944 261172477 34 533531 1 1
2026-07-14 424B5 424B5 0001104659-26-083268 333-284667 261172473 33 1101066
2026-07-13 8-K FORM 8-K 2.02,8.01 0001104659-26-082875 001-41944 261170011 34 196180 1 1
2026-05-29 4 FORM 4 0001777760-26-000016 5839
2026-05-29 3 FORM 3 0001777760-26-000015 11233
2026-05-28 8-K 8-K 5.02 0001999480-26-000016 001-41944 261028648 34 156183 1 1
2026-05-15 4 FORM 4 0002007795-26-000006 5296
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-002550 005-94343 26989596 34 10831
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003456 005-94343 26987456 34 17379
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000018 005-94343 26987196 34 15672
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003214 005-94343 26982424 34 17216
2026-05-14 4 FORM 4 0001830326-26-000005 5901
2026-05-14 4 FORM 4 0002008212-26-000004 5986
2026-05-14 4 FORM 4 0002009654-26-000004 5972
2026-05-14 4 FORM 4 0001670893-26-000002 5972
2026-05-14 4 FORM 4 0002008499-26-000005 5964
2026-05-13 8-K 8-K 5.02,5.07,9.01 0001999480-26-000014 001-41944 26973671 34 306603 1 1
2026-05-13 10-Q 10-Q 0001999480-26-000012 001-41944 26970939 34 7881976 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001999480-26-000011 001-41944 26970882 34 218916 1 1
2026-04-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001257 333-294974 26876627 33 1735
2026-04-17 CORRESP filename1.htm 0001104659-26-044747 9450
2026-04-16 UPLOAD filename1.pdf 0000000000-26-003880 333-294974 40049
2026-04-10 S-3 S-3 0001104659-26-041959 333-294974 26854757 33 784932 1 1
2026-04-01 8-K FORM 8-K 8.01,9.01 0001104659-26-038593 001-41944 26829165 34 215591 1 1
2026-03-26 ARS ARS 0001104659-26-035202 001-41944 26798301 34 2293964
2026-03-26 DEFA14A DEFA14A 0001104659-26-035191 001-41944 26798191 34 456648
2026-03-26 DEF 14A DEF 14A 0001104659-26-035180 001-41944 26798115 34 3112501 1 1
2026-03-16 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-26-027953 001-41944 26754433 34 783019 1 1
2026-03-16 S-8 FORM S-8 0001104659-26-027925 333-294309 26754384 33 223378 1 1
2026-03-16 10-K 10-K 0001999480-26-000002 001-41944 26754329 34 22552716 1 1
2026-03-16 8-K 8-K 2.02,9.01 0001999480-26-000001 001-41944 26754311 34 212164 1 1
2026-03-03 4 FORM 4 0002007795-26-000002 4969
2026-03-03 4 FORM 4 0002009130-26-000002 5007
2026-02-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001305 005-94343 26649329 34 10455
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001262 005-94343 26645124 34 10446
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-26-000894 005-94343 26642630 34 11746
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001136 005-94343 26642161 34 17598
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-26-000005 005-94343 26641379 34 15588
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001074 005-94343 26640912 34 14804
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054522 005-94343 26640552 34 11771
2026-02-13 4 FORM 4 0002007795-26-000001 5536
2026-02-13 4 FORM 4 0002008707-26-000001 5544
2026-02-13 4 FORM 4 0002009130-26-000001 5576
2026-02-13 4 FORM 4 0001791413-26-000001 5536
2026-01-06 4 FORM 4 0002008499-26-000002 5823
2026-01-06 4 FORM 4 0002008212-26-000002 5845
2026-01-06 4 FORM 4 0002009654-26-000002 5702
2026-01-06 4 FORM 4 0001830326-26-000002 5752
2025-12-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003645 333-291834 251563408 33 1736
2025-12-08 CORRESP filename1.htm 0001104659-25-119289 9591
2025-11-28 S-3 S-3 0001104659-25-116507 333-291834 251531741 33 758905 1 1
2025-11-12 10-Q 10-Q 0001999480-25-000090 001-41944 251469320 34 8764041 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001999480-25-000089 001-41944 251469074 34 235861 1 1
2025-10-27 D xslFormDX01/primary_doc.xml 06b 0001231919-25-000357 021-562189 251420650 33 13126
2025-10-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000022 005-94343 251419867 34 15195
2025-10-20 8-K FORM 8-K 1.01,1.02,3.02,8.01,9.01 0001104659-25-100801 001-41944 251403806 34 786574 1 1
2025-10-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-236739 005-94343 251387130 34 195413
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003614 005-94343 251222214 34 10628
2025-08-14 4 FORM 4 0001999480-25-000081 8213
2025-08-14 3 FORM 3 0001999480-25-000080 353673
2025-08-13 10-Q 10-Q 0001999480-25-000076 001-41944 251212219 34 8672355 1 1
2025-08-13 8-K 8-K 2.02,5.02,9.01 0001999480-25-000075 001-41944 251211702 34 271154 1 1
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002474 005-94343 251128435 34 10731
2025-07-08 4 FORM 4 0001999480-25-000065 17303
2025-07-08 4 FORM 4 0001999480-25-000064 26621
2025-07-08 4 FORM 4 0001999480-25-000063 22490
2025-07-08 4 FORM 4 0001999480-25-000062 27057
2025-07-08 8-K 8-K 5.02 0001999480-25-000061 001-41944 251111725 34 148076 1 1
2025-06-26 8-K 8-K 8.01,9.01 0001999480-25-000053 001-41944 251075077 34 171921 1 1
2025-06-03 8-K 8-K 1.01,3.02,8.01,9.01 0001999480-25-000048 001-41944 251017108 34 186337 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002412 005-94343 25953887 34 16912
2025-05-15 4 FORM 4 0001999480-25-000041 5851
2025-05-15 4 FORM 4 0001999480-25-000040 5865
2025-05-15 4 FORM 4 0001999480-25-000039 5851
2025-05-15 4 FORM 4 0001999480-25-000038 5843
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-25-001714 005-94343 25951875 34 17820
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002198 005-94343 25951740 34 10515
2025-05-14 10-Q 10-Q 0001999480-25-000037 001-41944 25946343 34 7792365 1 1
2025-05-14 8-K 8-K 2.02,5.07,9.01 0001999480-25-000035 001-41944 25945752 34 244896 1 1
2025-05-09 DEFR14A DEFR14A 0001193125-25-116871 001-41944 25930199 34 245387 1 1
2025-04-01 ARS ARS 0001193125-25-070465 001-41944 25800052 34 171054143
2025-04-01 DEFA14A DEFA14A 0001193125-25-070455 001-41944 25799969 34 321744
2025-04-01 DEF 14A DEF 14A 0001193125-25-070446 001-41944 25799888 34 1491384 1 1
2025-03-20 S-8 S-8 0001193125-25-059388 333-285978 25757771 33 284620
2025-03-20 10-K 10-K 0001999480-25-000025 001-41944 25757023 34 21275500 1 1
2025-03-20 8-K 8-K 2.02,5.02,9.01 0001999480-25-000024 001-41944 25756953 34 237094 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004261 005-94343 25631670 34 17091
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001014 005-94343 25628292 34 17120
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000740 005-94343 25612361 34 11394
2025-02-12 8-K 8-K 8.01,9.01 0001193125-25-024814 001-41944 25612106 34 173846 1 1
2025-02-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000401 333-284667 25611732 33 1742
2025-02-07 4 FORM 4 0001999480-25-000016 5541
2025-02-07 4 FORM 4 0001999480-25-000015 5581
2025-02-07 4 FORM 4 0001999480-25-000014 5546
2025-02-07 4 FORM 4 0001999480-25-000013 5541
2025-02-07 CORRESP filename1.htm 0001193125-25-022716 8469
2025-02-07 UPLOAD filename1.pdf 0000000000-25-001351 333-284667 40124
2025-02-03 8-K 8-K 1.01,2.02,9.01 0001193125-25-019318 001-41944 25583152 34 158005 1 1
2025-02-03 S-3 S-3 0001193125-25-019267 333-284667 25582529 33 1803138
2025-01-16 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-25-007383 001-41944 25534308 34 1033405 1 1
2025-01-06 4 FORM 4 0001999480-25-000006 5831
2025-01-06 4 FORM 4 0001999480-25-000005 5753
2025-01-06 4 FORM 4 0001999480-25-000004 5714
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119284 005-94343 241464721 34 93132
2024-11-14 SC 13G SC 13G 0001193125-24-257978 005-94343 241457060 34 45116
2024-11-12 10-Q 10-Q 0001999480-24-000042 001-41944 241448679 34 9360844 1 1
2024-11-12 8-K 8-K 2.02,9.01 0001999480-24-000040 001-41944 241448554 34 243838 1 1
2024-11-12 SC 13G filing.txt 0000315066-24-002687 005-94343 241444465 34 8150
2024-11-08 SC 13G us02157q1094_110824.txt 0002012383-24-003409 005-94343 241439539 34 13610
2024-10-22 8-K 8-K 8.01,9.01 0001193125-24-241092 001-41944 241386708 34 179682 1 1
2024-10-21 SC 13G us02157q1094_102124.txt 0002012383-24-000973 005-94343 241383604 34 13598
2024-08-13 10-Q 10-Q 0001999480-24-000035 001-41944 241202300 34 8731575 1 1
2024-08-13 8-K 8-K 2.02,9.01 0001999480-24-000033 001-41944 241202233 34 245214 1 1
2024-07-29 8-K 8-K 1.01,2.03,3.02,9.01 0001999480-24-000025 001-41944 241152627 34 529506 1 1
2024-07-11 4 xslF345X05/form4-07112024_040701.xml 0001415889-24-019488 9116
2024-05-22 4 xslF345X05/form4-05222024_090504.xml 0001415889-24-014118 5578
2024-05-22 3 xslF345X02/form3-05222024_090532.xml 0001415889-24-014115 11493
2024-05-21 8-K 8-K 5.02 0001193125-24-143369 001-41944 24966913 34 152406 1 1
2024-05-14 10-Q 10-Q 0001999480-24-000022 001-41944 24945002 34 7864670 1 1
2024-05-14 8-K 8-K 2.02,9.01 0001999480-24-000020 001-41944 24944792 34 218439 1 1
2024-04-01 4 xslF345X05/form4-04012024_040402.xml 0001415889-24-009533 6074
2024-03-29 SC 13G SC 13G 0001104659-24-041071 005-94343 24803162 34 77024
2024-03-21 10-K 10-K 0001999480-24-000010 001-41944 24771749 34 18163384
2024-03-21 8-K 8-K 2.02,9.01 0001999480-24-000008 001-41944 24771635 34 81415
2024-03-12 4 xslF345X05/form4-03122024_080330.xml 0001415889-24-007643 8101
2024-03-12 3 xslF345X02/form3-03122024_080332.xml 0001415889-24-007641 9840
2024-03-11 8-K 8-K 5.02 0001193125-24-064372 001-41944 24736632 34 149520 1 1
2024-03-06 4 4 0000950170-24-026885 19869
2024-03-05 4 xslF345X05/form4-03052024_060306.xml 0001415889-24-006824 5544
2024-03-05 4 xslF345X05/form4-03052024_060303.xml 0001415889-24-006823 7506
2024-03-05 4 xslF345X05/form4-03052024_060301.xml 0001415889-24-006822 7482
2024-02-09 SC 13G ALTO NEUROSCIENCE, INC. 0000902664-24-001347 005-94343 24611942 34 91146
2024-02-08 4 xslF345X05/ownership.xml 0000902664-24-001290 20585
2024-02-07 4 xslF345X05/form4-02072024_090216.xml 0001415889-24-002942 6989
2024-02-07 4 xslF345X05/form4-02072024_090252.xml 0001415889-24-002940 4598
2024-02-07 4 xslF345X05/form4-02072024_090202.xml 0001415889-24-002938 11713
2024-02-07 4 xslF345X05/form4-02072024_090257.xml 0001415889-24-002936 8983
2024-02-07 4 xslF345X05/form4-02072024_090241.xml 0001415889-24-002934 8481
2024-02-07 4 xslF345X05/form4-02072024_090224.xml 0001415889-24-002932 10898
2024-02-07 SC 13G ALTO NEUROSCIENCE, INC. 0000902664-24-001227 005-94343 24604695 34 114314
2024-02-06 S-8 S-8 0001193125-24-025355 333-276901 24601005 33 326691
2024-02-06 8-K 8-K 5.03,9.01 0001193125-24-025266 001-41944 24600265 34 355069 1 1
2024-02-05 4 xslF345X05/form4-02052024_090213.xml 0001415889-24-002570 8076
2024-02-05 4 xslF345X05/form4-02052024_090245.xml 0001415889-24-002567 8085
2024-02-05 4 xslF345X05/form4-02052024_090247.xml 0001415889-24-002563 8093
2024-02-05 4 xslF345X05/form4-02052024_090258.xml 0001415889-24-002558 8100
2024-02-05 4 xslF345X05/form4-02052024_090236.xml 0001415889-24-002553 5443
2024-02-05 424B4 424B4 0001193125-24-023429 333-276495 24593928 33 6058328
2024-02-02 3 xslF345X02/form3-02022024_090257.xml 0001415889-24-002344 17483
2024-02-02 SEC STAFF LETTER filename1.pdf 9999999997-24-000234 64002
2024-02-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-02-01 16:30:00 9999999995-24-000286 333-276495 24588667 33 1728
2024-02-01 3 xslF345X02/form3-02012024_110254.xml 0001415889-24-002217 9711
2024-02-01 3 xslF345X02/form3-02012024_110215.xml 0001415889-24-002214 11052
2024-02-01 3 xslF345X02/ownership.xml 0000902664-24-000914 13420
2024-02-01 3 xslF345X02/form3-02012024_110251.xml 0001415889-24-002213 16416
2024-02-01 3 xslF345X02/form3-02012024_110214.xml 0001415889-24-002212 13811
2024-02-01 3 xslF345X02/form3-02012024_110238.xml 0001415889-24-002211 16741
2024-02-01 3 xslF345X02/ownership.xml 0001206774-24-000070 6706
2024-02-01 3 xslF345X02/form3-02012024_110204.xml 0001415889-24-002210 13218
2024-02-01 3 xslF345X02/form3-02012024_110218.xml 0001415889-24-002209 16988
2024-02-01 3 xslF345X02/form3-02012024_110204.xml 0001415889-24-002208 12550
2024-02-01 S-1MEF S-1MEF 0001193125-24-022010 333-276828 24588259 33 64225
2024-01-30 CERT NYSE CERTIFICATION 0000876661-24-000077 001-41944 24578806 34 28907
2024-01-30 8-A12B 8-A12B 0001193125-24-019402 001-41944 24578125 34 13893
2024-01-30 CORRESP filename1.htm 0001193125-24-019400 10261
2024-01-30 CORRESP filename1.htm 0001193125-24-019393 7451
2024-01-29 S-1/A S-1/A 0001193125-24-017660 333-276495 24571098 33 78653
2024-01-29 S-1/A S-1/A 0001193125-24-017403 333-276495 24570110 33 7879109
2024-01-25 CORRESP filename1.htm 0001193125-24-015223 22009
2024-01-24 CORRESP filename1.htm 0001193125-24-014558 62328
2024-01-23 UPLOAD filename1.pdf 0000000000-24-000921 377-06967 47571
2024-01-19 CORRESP filename1.htm 0001193125-24-011418 78183
2024-01-12 CORRESP filename1.htm 0001193125-24-007598 41803
2024-01-12 S-1 S-1 0001193125-24-007592 333-276495 24532613 33 8858605
2024-01-09 SEC STAFF LETTER filename1.pdf 9999999997-24-000147 64909
2024-01-09 UPLOAD filename1.pdf 0000000000-24-000314 377-06967 50492
2023-12-28 DRSLTR filename1.htm 0000950123-23-011331 98269
2023-12-28 DRS/A filename1.htm 0000950123-23-011330 377-06967 231523540 33 7271479
2023-12-19 UPLOAD filename1.pdf 0000000000-23-013834 377-06967 87743
2023-11-27 D xslFormDX01/primary_doc.xml 06b 0001999480-23-000004 021-498128 231440030 33 13455
2023-11-27 D xslFormDX01/primary_doc.xml 06b 0001999480-23-000003 021-498127 231440018 33 13455
2023-11-27 D xslFormDX01/primary_doc.xml 06b 0001999480-23-000002 021-498125 231440012 33 13519
2023-11-27 D xslFormDX01/primary_doc.xml 06b 0001999480-23-000001 021-498123 231440003 33 13453
2023-11-22 DRS filename1.htm 0000950123-23-011078 377-06967 231433704 33 6685864

Latest XBRL company facts

One latest value per concept from companyfacts (197 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 40.11M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
dei EntityPublicFloat Entity Public Float USD 55.20M 2025-06-30 2025 FY 10-K 2026-03-16 0001999480-26-000002
ffd NetFeeAmt NetFeeAmt USD 17,914.33 2026-04-09 S-3 2026-04-10 0001104659-26-041959
ffd TtlFeeAmt TtlFeeAmt USD 17,914.33 2026-04-09 S-3 2026-04-10 0001104659-26-041959
ffd TtlOfferingAmt TtlOfferingAmt USD 129.72M 2026-04-09 S-3 2026-04-10 0001104659-26-041959
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-09 S-3 2026-04-10 0001104659-26-041959
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-09 S-3 2026-04-10 0001104659-26-041959
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.85M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 577.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD -190,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 3.52M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 115,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 9.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 16,332 2024-05-29 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap Assets Assets USD 326.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AssetsCurrent Assets, Current USD 323.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 319.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 319.34M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 319.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 142.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 14.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 39.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 39.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ConvertibleDebt Convertible Debt USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.02 2024-07-01 2024-07-31 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 10.00M 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 105,000 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.49M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 53.63M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.49M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 19.79M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 6.61M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.42M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.14M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 52.14M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.19M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 293,000 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap Depreciation Depreciation USD 549,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 340,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001999480-25-000076
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.225 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.026 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.025 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 1.40M 2025-07-31 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 281,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 22.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 14.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 134,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -13.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 581,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 137,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -8,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999480-24-000042
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap InterestPayableCurrent Interest Payable, Current USD 88,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 6.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LeaseCost Lease, Cost USD 1.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 432,000 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.54M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.50M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.46M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 263,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 158,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap Liabilities Liabilities USD 29.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 326.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LiabilitiesCurrent Liabilities, Current USD 17.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LongTermDebt Long-term Debt USD 10.25M 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 4.51M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 4.77M 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 5.23M 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999480-24-000042
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 8.97M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 211.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -556,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -67.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -79.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxParent OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTaxParent USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingExpenses Operating Expenses USD 83.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -83.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 673,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingLeasePayments Operating Lease, Payments USD 863,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 868,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.101 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherAssets Other Assets USD 66,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherAssetsCurrent Other Assets, Current USD 23,000 2025-03-31 2025 Q1 10-Q 2025-05-14 0001999480-25-000037
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -79.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 3.06M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001999480-24-000042
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 190,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 556,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-02-06 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2024-02-06 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.11M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001999480-26-000023
us-gaap PrepaidInsurance Prepaid Insurance USD 799,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 19.69M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001999480-25-000037
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 60.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -280.63M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 9.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 27,000 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 14.88 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 27,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 14.88 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 157,367 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001999480-25-000090
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 2.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 4.23M 2025-07-31 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 2.35 2025-07-03 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 16 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 296.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio Rate 0.45 2024-01-01 2024-01-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 72,631 2021-05-01 2021-05-31 2025 Q3 10-Q 2025-11-12 0001999480-25-000090
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 141.48M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 94.25M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.77M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 6.60M 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 146.70M 2023-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 31.51M 2023-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 29.92M 2023-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 24.85M 2023-01-01 2023-03-31 2024 Q3 10-Q 2024-11-12 0001999480-24-000042
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 163,000 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 7.10M 2024-05-29 2024 Q2 10-Q 2024-08-13 0001999480-24-000035
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 14.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap VariableLeaseCost Variable Lease, Cost USD 269,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001999480-26-000002
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0001999480-25-000025
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 42.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 42.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001999480-26-000031

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →